Filing Details

Accession Number:
0000950170-25-023681
Form Type:
13D Filing
Publication Date:
2025-02-18 19:00:00
Filed By:
Deep Track Capital
Company:
Dynavax Technologies Corp (NASDAQ:DVAX)
Filing Date:
2025-02-19
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Deep Track Biotechnology Master Fund, Ltd. 0 17,791,486 0 17,791,486 17,791,486 13.5%
Deep Track Capital, LP 0 17,791,486 0 17,791,486 17,791,486 13.5%
David Kroin 0 17,791,486 0 17,791,486 17,791,486 13.5%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
Deep Track Biotechnology Master Fund, Ltd.
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Director
Date:02/19/2025
 
Deep Track Capital, LP
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner of Deep Track Capital, LP
Date:02/19/2025
 
David Kroin
 
Signature:/s/ David Kroin
Name/Title:David Kroin
Date:02/19/2025
Comments accompanying signature:
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.